e-learning
resources
Paris 2018
Sunday, 16.09.2018
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term use of inhaled glucocorticoids in stable chronic obstructive pulmonary disease patients and risk of diabetes mellitus: systematic review of the literature
F. Arpinelli (Verona, Italy), P. Ruggeri (Messina, Italy), G. Girbino (Messina, Italy), G. Caramori (Messina, Italy)
Source:
International Congress 2018 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
Thematic Poster
Number:
770
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Arpinelli (Verona, Italy), P. Ruggeri (Messina, Italy), G. Girbino (Messina, Italy), G. Caramori (Messina, Italy). Long-term use of inhaled glucocorticoids in stable chronic obstructive pulmonary disease patients and risk of diabetes mellitus: systematic review of the literature. 770
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A preliminary meta-analysis of long-term inhaled steroids for stable chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Prevalence of undiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Treatment of pulmonary hypertension associated with COPD: a systematic review
Source: ERJ Open Res, 8 (1) 00348-2021; 10.1183/23120541.00348-2021
Year: 2022
Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
The effect of diabetes mellitus on chronic obstructive pulmonary disease exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A meta-analysis of clinically relevant outcomes
Source: Annual Congress 2010 - COPD: management
Year: 2010
Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002
Inhaled steroids and prevalence of osteoporosis in chronic obstructive pulmonary disease: Data from the DACCORD cohort
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Early supported discharge/hospital at home for exacerbation of chronic obstructive pulmonary disease, A review and meta-analysis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Medication use in COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
²Hospital at home² versus inpatient care for patients with acute exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 445s
Year: 2003
Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept